Bela Denes
Chief Tech/Sci/R&D Officer chez LANTHEUS HOLDINGS, INC.
Postes actifs de Bela Denes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LANTHEUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 07/04/2021 | - |
| American College of Surgeons | Corporate Officer/Principal | - | - |
Historique de carrière de Bela Denes
Anciens postes connus de Bela Denes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - | - |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Chief Tech/Sci/R&D Officer | 01/04/2012 | - |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
- Bourse
- Insiders
- Bela Denes
- Expérience
